全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

社区精神分裂症患者服药依从性及原因分析
Analysis of Medication Compliance and Reasons for Patients with Schizophrenia in the Community

DOI: 10.12677/acm.2024.1461749, PP. 88-93

Keywords: 社区,精神分裂症,服药依从性
Community
, Schizophrenia, Medication Compliance

Full-Text   Cite this paper   Add to My Lib

Abstract:

精神分裂症被认为是一种高复发率、高致残率的重性精神疾病,该病患者基数庞大,且预后不良。目前,药物治疗被视为是维持疾病稳定和减少疾病复发的重要手段,社区康复则被视为是大部分患者疾病恢复的一个重要过程。实际上,社区精神分裂症患者存在服药依从性差、家庭监护能力弱、肇事肇祸风险高等问题,不仅不利于患者的病情恢复,也对经济发展和社会稳定构成了威胁。因此,改善社区精神分裂症患者的服药依从性,分析服药依从性的影响因素成为关键。本文就近5年国内外有关社区精神分裂症患者服药依从性状况及其影响因素做一综述,以期为今后的临床研究和相关干预措施提供参考。
Schizophrenia is considered as a severe mental illness with a high recurrence rate and a high disability rate, with a large patient base and a poor prognosis. At present, drug treatment is regarded as an important means to maintain disease stability and reduce disease recurrence, while community rehabilitation is regarded as an important process of disease recovery of most patients. However, in fact, the community patients with schizophrenia have poor medication compliance, weak family monitoring ability, and high risk of causing accidents, which are not only detrimental to the patients’ condition recovery, but also pose a threat to the economic development and social stability. Therefore, how to improve medication compliance for schizophrenic patients and analyze the factors affecting medication adherence become key. This paper summarizes the medication adherence and element of schizophrenia at home and abroad, in order to provide reference for future clinical research and related interventions.

References

[1]  Owen, M.J., Sawa, A. and Mortensen, P.B. (2016) Schizophrenia. The Lancet, 388, 86-97.
https://doi.org/10.1016/S0140-6736(15)01121-6
[2]  Li, Y., Wen, H., Xu, J., et al. (2020) The Association between Medication Adherence and Disease Stability in Patients with Severe Mental Disorders and Area Variation: Community-Based Prospective Study in Southwest China. Community Mental Health Journal, 56, 322-327.
https://doi.org/10.1007/s10597-019-00460-2
[3]  李延红, 姜长青, 辛刚, 等. 精神分裂症患者家属生活质量及影响因素的研究[J]. 首都医科大学学报, 2008, 29(5): 555-558.
[4]  Panish, J., Karve, S., Candrilli, S.D., et al. (2013) Association between Adherence to and Persistence with Atypical Antipsychotics and Psychiatric Relapse among US Medicaid-Enrolled Patients with Schizophrenia. Journal of Pharmaceutical Health Services Research, 4, 29-39.
https://doi.org/10.1111/jphs.12004
[5]  孙秀珍, 李艳青, 纪爱建. 自知力教育对精神分裂症患者自知力及服药依从性的影响[J]. 中国临床康复, 2005, 9(8): 193.
[6]  Zhou, Y., Rosenheck, R., Mohamed, S., et al. (2017) Factors Associated with Complete Discontinuation of Medication among Patients with Schizophrenia in the Year after Hospital Discharge. Psychiatry Research, 250, 129-135.
https://doi.org/10.1016/j.psychres.2017.01.036
[7]  宓为峰, 邹连勇, 李梓萌, 等. 精神分裂症患者用药依从性及复发情况的调查[J]. 中华精神科杂志, 2012, 45(1): 25-28.
[8]  Dassa, D., Boyer, L., Benoit, M., et al. (2010) Factors Associated with Medication Non-Adherence in Patients Suffering from Schizophrenia: A Cross-Sectional Study in a Universal Coverage Health-Care System. Australian & New Zealand Journal of Psychiatry, 44, 921-928.
https://doi.org/10.3109/00048674.2010.493503
[9]  Eticha, T., Teklu, A., Ali, D., et al. (2015) Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia. PLOS ONE, 10, e0120560.
https://doi.org/10.1371/journal.pone.0120560
[10]  Bressington, D., Mui, J. and Gray, R. (2013) Factors Associated with Antipsychotic Medication Adherence in Community-Based Patients with Schizophrenia in Hong Kong: A Cross Sectional Study. International Journal of Mental Health Nursing, 22, 35-46.
https://doi.org/10.1111/j.1447-0349.2012.00830.x
[11]  Yu, W., Tong, J., Sun, X., et al. (2021) Analysis of Medication Adherence and Its Influencing Factors in Patients with Schizophrenia in the Chinese Institutional Environment. International Journal of Environmental Research and Public Health, 18, Article 4746.
https://doi.org/10.3390/ijerph18094746
[12]  王勋, 马宁, 吴霞民, 等. 社区精神分裂症患者服药依从性及原因分析[J]. 中国神经精神疾病杂志, 2016, 42(6): 374-378.
[13]  陈云芳, 步建梅. 精神分裂症患者院外服药依从性的影响因素[J]. 武警后勤学院学报(医学版), 2013, 22(3): 182-184.
[14]  Moritz, S., Favrod, J., Andreou, C., et al. (2013) Beyond the Usual Suspects: Positive Attitudes towards Positive Symptoms Is Associated with Medication Noncompliance in Psychosis. Schizophrenia Bulletin, 39, 917-922.
https://doi.org/10.1093/schbul/sbs005
[15]  周晓燕, 杨立身, 洪荣静. 出院精神病人服药依从性相关因素的城乡对照[J]. 现代医药卫生, 2011, 27(6): 905-906.
[16]  Tattan, T.M. and Creed, F.H. (2001) Negative Symptoms of Schizophrenia and Compliance with Medication. Schizophrenia Bulletin, 27, 149-155.
https://doi.org/10.1093/oxfordjournals.schbul.a006853
[17]  孙莉, 谢红涛, 陈俊, 王祖承. 服药依从性良好的社区精神分裂症患者相关特点分析[J]. 药物流行病学杂志, 2019, 28(6): 408-412.
[18]  乔卫红, 黄健. 精神分裂症患者服药依从性和复发率调查分析[J]. 中国实用神经疾病杂志, 2014, 17(18): 47-48.
[19]  陈蕙, 王延祜. 社区精神分裂症患者服药依从性研究进展[J]. 临床精神医学杂志, 2020, 30(6): 454-456.
[20]  何爱玲. 社区精神分裂症患者服药依从性的调查及应对策略[J]. 中国民康医学, 2013, 25(24): 120-121.
[21]  Schoeler, T., Petros, N., Di Forti, M., et al. (2017) Poor Medication Adherence and Risk of Relapse Associated with Continued Cannabis Use in Patients with First-Episode Psychosis: A Prospective Analysis. The Lancet Psychiatry, 4, 627-633.
https://doi.org/10.1016/S2215-0366(17)30233-X
[22]  Yao, L., Liu, H. and Tian, X. (2022) Medication Adherence among Community-Dwelling Schizophrenia Patients during the COVID-19 Pandemic: A Cross-Sectional Study. Psychiatry Research, 317, Article 114841.
https://doi.org/10.1016/j.psychres.2022.114841
[23]  Pan, Y.-J., Kuo, K.-H. and Yeh, L.-L. (2019) Healthcare Cost, Service Use and Mortality in Major Psychiatric Disorders in Taiwan. Journal of Affective Disorders, 246, 112-120.
https://doi.org/10.1016/j.jad.2018.12.046
[24]  Rotstein, A., Roe, D., Gelkopf, M., et al. (2018) Age of Onset and Quality of Life among Males and Females with Schizophrenia: A National Study. European Psychiatry, 53, 100-106.
https://doi.org/10.1016/j.eurpsy.2018.06.004
[25]  Acosta, F.J., Hernández, J.L., Pereira, J., et al. (2012) Medication Adherence in Schizophrenia. World Journal of Psychiatry, 2, 74-82.
https://doi.org/10.5498/wjp.v2.i5.74
[26]  刘浉妍, 罗兴伟, 赵伟, 等. 慢性精神分裂症家属照护体验及负担的质性研究[J]. 中国临床心理学杂志, 2015, 23(2): 262-267.
[27]  Ansari, S. and Mulla, S. (2014) Analysis of Variables Affecting Drug Compliance in Schizophrenia. Industrial Psychiatry Journal, 23, 58-60.
https://doi.org/10.4103/0972-6748.144968
[28]  王勋, 马宁, 王立英, 等. 2014年全国严重精神障碍患者管理信息分析[J]. 中华精神科杂志, 2016, 49(3): 182-188.
[29]  康瑞莹, 吴业清, 杨向东, 等. 社区卫生服务中心贫困精神病患者免费服药的治疗效果随访分析[J]. 中国全科医学, 2013, 16(28): 3376-3378.
[30]  沈渔邨. 精神病学[M]. 北京: 人民卫生出版社, 2017: 300-301.
[31]  钱程, 陈楠, 邹义壮. 精神分裂症患者的自知力[J]. 中国心理卫生杂志, 2019, 33(2): 87-92.
[32]  Folsom, D.P., Depp, C., Palmer, B.W., et al. (2009) Physical and Mental Health-Relatedqualily of Life among Older People with Schizophrenia. Schizophrenia Research, 108, 207-213.
https://doi.org/10.1016/j.schres.2008.12.008
[33]  马莉莉, 管晓东, 信枭雄, 等. 依从性评价方法研究综述[J]. 中国药事, 2016, 30(4): 388-393.
[34]  郭全芳, 孔媛, 张云红. 社区精神分裂症病人服药依从性分析[J]. 全科护理, 2009, 7(1): 90-91.
[35]  胡人文, 李弘. 自知力教育对精神分裂症患者自知力恢复及服药依从性的研究[J]. 中华精神科杂志, 1998, 31(3): 145-147.
[36]  Kalkan, E. and Budak, F.K. (2020) The Effect of Insights on Medication Adherence in Patients with Schizophrenia. Perspectives in Psychiatric Care, 56, 222-228.
https://doi.org/10.1111/ppc.12414
[37]  孙艳平, 王宏杰, 刘玉红, 等. 一体化护理干预对社区精神分裂症患者免费服药依从性的影响[J]. 护理实践与研究, 2021, 18(2): 293-296.
[38]  周红, 钱斌, 龚兴波, 等. 主动式社区治疗模式对精神分裂症患者服药依从性和精神症状的影响[J]. 上海医药, 2019, 40(24): 45-47, 59.
[39]  赵静, 吕钦谕, 郭向晴, 等. 积极式个案管理对社区精神分裂症复发及卫生经济学影响[J]. 中国神经精神疾病杂志, 2014, 40(11): 666-672.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133